Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 633
Selected: 0
NCT IDTitle
NCT06938503AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer
NCT07047560Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study
NCT06717009A Study of 3D Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors.
NCT07791550Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy
NCT07654530Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.
NCT04908566Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
NCT04973306Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
NCT06474481Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma
NCT01634971External Drainage Versus Internal Drainage of Pancreatic Duct With a Stent After Pancreaticoduodenectomy (EDIDPD)
NCT07707622Sepsis in Critically Ill Patients
NCT01745107Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
NCT06339307A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients
NCT04218253Clinical Application of Nutrition Support Package Before Hepatectomy
NCT05035381PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer
NCT06073730Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients
NCT03299738A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL
NCT04843215A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
NCT07460596Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea
NCT02845882LBL-2016 for Children or Adolescents in China
NCT06890182Firmonertinib Combined With Chemotherapy as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutanted NSCLC
NCT07432568A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC
NCT07888413Effect of Low-Dose Esketamine Combined With Dexmedetomidine on the Incidence of Chronic Postsurgical Pain in Patients Undergoing Pancreatic Surgery
NCT03046979Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)
NCT05854030Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma
NCT04128800Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer
NCT07065175KANGFUPEN Liquid Dressing for Chronic Radiation-Induced Rectal Injury
NCT03743324Effect of Radiation and Its Timing on Breast Reconstruction in Chinese Patients
NCT05637268Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma
NCT05820906Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer
NCT02745509Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (SEIPLUS)
NCT05522985Toripalimab-based Neoadjuvant Therapy in LA-HNSCC
NCT07058948Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors
NCT07240753A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma
NCT04782765Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma
NCT05356351An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer
NCT06289751Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
NCT04103853Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
NCT04245930Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.
NCT07723729Butyrate Yogurt for Cancer Constipation
NCT06370065Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
NCT07179445Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy
NCT06241612Individualized Elective Neck Irradiation in NPC Patients
NCT07840092Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma
NCT06496789Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer
NCT06463691Sonrotoclax, Zanubrutinib and CD20mab in Untreated MCL Patients
NCT07594925Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical Trial
NCT01322776Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma
NCT05778149Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation
NCT02497118Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC
NCT07528274Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure